PROFUSA, INC. Financing Cash Flow
PROFUSA, INC. (PFSA) reported Financing Cash Flow of $3.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-19
- PROFUSA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.05M, a 400.66% increase year-over-year.
- PROFUSA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $28.00K, a 92.33% decline year-over-year.
- PROFUSA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $4.91M, a 1597.58% increase year-over-year.
- PROFUSA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $13.96M, a 270.33% increase year-over-year.
- PROFUSA, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$183.72M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $3.08M 10-Q · filed 2026-08-19 | $7.98M derived: sum of 3 quarters · filed 2026-08-19 | $21.95M derived: sum of 4 quarters · filed 2026-08-19 | |||||
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-15 | $4.93M derived: sum of 2 quarters · filed 2026-05-15 | $18.90M derived: sum of 3 quarters · filed 2026-05-15 | $19.51M derived: sum of 4 quarters · filed 2026-08-19 | |||||
| 2025-12-31 | $4.91M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $18.87M derived: sum of 2 quarters · filed 2026-05-01 | $19.48M derived: sum of 3 quarters · filed 2026-08-19 | $19.84M S-1/A · filed 2026-05-01 | |||||
| 2025-09-30 | $13.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $14.57M derived: sum of 2 quarters · filed 2026-08-19 | $14.94M 10-Q · filed 2025-11-19 | $15.23M derived: sum of 4 quarters · filed 2026-08-19 | |||||
| 2025-06-30 | $609.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $974.00K 10-Q · filed 2026-08-19 | -$6.00M 10-Q · filed 2025-08-14 | $1.26M derived: sum of 3 quarters · filed 2026-08-19 | $5.03M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $365.00K 10-Q · filed 2026-05-15 | -$6.13M 10-Q · filed 2025-06-13 | $654.00K derived: sum of 2 quarters · filed 2026-05-15 | $4.42M derived: sum of 3 quarters · filed 2026-05-15 | $4.76M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $289.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $4.06M derived: sum of 2 quarters · filed 2026-05-01 | $4.39M derived: sum of 3 quarters · filed 2026-05-01 | $2.12M S-1/A · filed 2026-05-01 | -$1.66M 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $4.10M derived: sum of 2 quarters · filed 2025-11-19 | $1.83M 10-Q · filed 2025-11-19 | -$1.54M 10-Q · filed 2024-12-17 | $2.23M derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | $330.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.94M 10-Q · filed 2025-08-14 | -$1.54M derived: sum of 3 quarters · filed 2025-08-14 | -$1.19M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | -$2.28M 10-Q · filed 2025-06-13 | -$1.87M derived: sum of 2 quarters · filed 2025-06-13 | -$1.52M derived: sum of 3 quarters · filed 2025-06-13 | -$1.15M derived: sum of 4 quarters · filed 2025-06-13 | |||||
| 2023-12-31 | $408.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $752.23K derived: sum of 2 quarters · filed 2025-03-31 | $1.12M derived: sum of 3 quarters · filed 2025-03-31 | -$183.72M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $343.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $713.01K derived: sum of 2 quarters · filed 2024-12-17 | -$184.13M 10-Q · filed 2024-12-17 | ||||||
| 2023-06-30 | $369.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-15 | -$184.48M 10-Q · filed 2024-11-15 | |||||||
| 2023-03-31 | -$184.85M 10-Q · filed 2024-10-09 | ||||||||
| 2021-12-31 | $193.08M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |